Concorde Asset Management, LLC Royalty Pharma PLC Transaction History

Concorde Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$37.46 - $42.44 $193,593 - $219,329	-5,168 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$35.17 - $42.48 $191,395 - $231,176	-5,442 Reduced 51.29%	5,168 $206,000
Q3 2021 Oct 21, 2021	BUY	$36.14 - $42.24 $795 - $929	22 Added 0.21%	10,610 $383,000
Q2 2021 Jul 20, 2021	SELL	$39.85 - $46.63 $23,192 - $27,138	-582 Reduced 5.21%	10,588 $434,000
Q1 2021 Apr 27, 2021	BUY	$42.34 - $52.82 $472,937 - $589,999	11,170 New	11,170 $487,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Concorde Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Concorde Asset Management, LLC with notifications on news.